Immunology
-
SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection
This article has 16 authors:Reviewed by ScreenIT
-
Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins
This article has 8 authors:Reviewed by ScreenIT
-
Development of highly potent neutralising nanobodies against multiple SARS-CoV-2 variants including the variant of concern B.1.351
This article has 7 authors:Reviewed by ScreenIT
-
SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies
This article has 27 authors:Reviewed by ScreenIT
-
Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells
This article has 16 authors:Reviewed by ScreenIT
-
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19
This article has 42 authors:Reviewed by ScreenIT
-
Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation
This article has 9 authors:Reviewed by ScreenIT
-
An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity
This article has 13 authors:Reviewed by ScreenIT
-
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates
This article has 59 authors:Reviewed by ScreenIT
-
Enhanced immunogenicity of a synthetic DNA vaccine expressing consensus SARS-CoV-2 Spike protein using needle-free immunization
This article has 12 authors:Reviewed by ScreenIT